We are live on ! Find out more
AKBA icon

Akebia Therapeutics
AKBA

189 hedge funds and large institutions have $1.52B invested in Akebia Therapeutics in 2020 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 77 increasing their positions, 43 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

765% more call options, than puts

Call options by funds: $26.1M | Put options by funds: $3.02M

262% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 13

115% more capital invested

Capital invested by funds: $703M → $1.52B (+$812M)

79% more repeat investments, than reductions

Existing positions increased: 77 | Existing positions reduced: 43

22% more funds holding

Funds holding: 155 → 189 (+34)

7.55% more ownership

Funds ownership: 71.45% → 79% (+7.5%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
189
Holders Change
+34
Holders Change %
+21.94%
% of All Funds
3.88%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
47
Increased
77
Reduced
43
Closed
13
Calls
$26.1M
Puts
$3.02M
Net Calls
+$23.1M
Net Calls Change
+$13.6M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$57.4M
2
GPP
Great Point Partners
Connecticut
+$36.3M
3
State Street
State Street
Massachusetts
+$16.5M
4
PAMU
Pictet Asset Management (UK)
United Kingdom
+$16.1M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$14.8M

Top Sellers

1
BG
Baupost Group
Massachusetts
-$26.2M
2
NHAS
Novo Holdings A/S
Denmark
-$14.5M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$12.8M
4
Millennium Management
Millennium Management
New York
-$6.52M
5
FCM
Farallon Capital Management
California
-$5.17M
Name Holding Trade Value Shares
Change 		Change in
Stake
BG
1
Baupost Group
Massachusetts
$204M -$26.2M -2,527,968 -14%
BlackRock
2
BlackRock
New York
$154M +$12.7M +1,229,244 +12%
Vanguard Group
3
Vanguard Group
Pennsylvania
$99.4M +$14.8M +1,435,322 +24%
Wellington Management Group
4
Wellington Management Group
Massachusetts
$98.8M +$57.4M +5,549,182 +322%
CCM
5
Consonance Capital Management
New York
$95.5M -$931K -90,000 -1%
NCM
6
Nantahala Capital Management
Connecticut
$82.9M -$4.74M -458,367 -7%
ACM
7
Abrams Capital Management
Massachusetts
$76.8M – – –
State Street
8
State Street
Massachusetts
$68.1M +$16.5M +1,595,108 +47%
GPP
9
Great Point Partners
Connecticut
$47.7M +$36.3M +3,510,073 New
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
$31.5M +$10.4M +1,009,842 +77%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$28.5M +$2.87M +276,943 +15%
NHAS
12
Novo Holdings A/S
Denmark
$27M -$14.5M -1,405,533 -41%
Dimensional Fund Advisors
13
Dimensional Fund Advisors
Texas
$25.8M +$572K +55,298 +3%
Northern Trust
14
Northern Trust
Illinois
$24.1M +$3.16M +305,838 +21%
Fidelity Investments
15
Fidelity Investments
Massachusetts
$24.1M +$7.71M +745,500 +73%
N
16
Nuveen
North Carolina
$21.4M +$901K +87,084 +6%
PAMU
17
Pictet Asset Management (UK)
United Kingdom
$21.1M +$16.1M +1,552,384 New
ClearBridge Investments
18
ClearBridge Investments
New York
$20.7M +$562K +54,354 +4%
RHJA
19
Rice Hall James & Associates
California
$18.6M -$355K -34,276 -2%
CS
20
Candriam SCA
Luxembourg
$16.7M +$12.7M +1,229,346 New
LGM
21
Logos Global Management
California
$16.3M +$12.4M +1,200,000 New
Goldman Sachs
22
Goldman Sachs
New York
$15.4M +$3.78M +365,281 +47%
Invesco
23
Invesco
Georgia
$14.8M -$443K -42,816 -4%
Charles Schwab
24
Charles Schwab
California
$14.2M +$3.15M +304,312 +41%
Norges Bank
25
Norges Bank
Norway
$13.2M +$517K +50,000 +5%
1
2 3 4 5

AKBA Hedge Fund Activity: Q2 2020 in Review

189 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Akebia Therapeutics (AKBA) for Q2 2020, worth a combined $1.52B — up 115% from $703M a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new AKBA positions and 13 closed out — a net gain of 34 holders — while 77 added to existing stakes and 43 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $57.4M. The largest seller was Baupost Group, cutting an estimated $26.2M.

  • 189 institutional investors held Akebia Therapeutics (AKBA) as of Q2 2020, up from 155 in Q1 2020.
  • Funds reported $1.52B of Akebia Therapeutics stock for Q2 2020, up 115% quarter-over-quarter.
  • 47 funds opened new Akebia Therapeutics positions in Q2 2020 and 13 closed out, a net change of +34 holders.
  • The largest Akebia Therapeutics buyer in Q2 2020 was Wellington Management Group, an estimated $57.4M added.
  • The largest Akebia Therapeutics seller in Q2 2020 was Baupost Group, an estimated $26.2M sold.

Based on aggregated 13F filings for Q2 2020.